Gottardi E - Search Results

1

Retrospective comparison of qualitative and quantitative reverse transcriptase polymerase chain reaction in diagnosing and monitoring the ALL1-AF4 fusion transcript in patients with acute lymphoblastic leukaemia.

Elia L, Gottardi E, Floriddia G, Grillo R, Ciambelli F, Luciani M, Chiusolo P, Invernizzi R, Meloni G, Foà R, Saglio G, Cimino G. Elia L, et al. Among authors: gottardi e. Leukemia. 2004 Nov;18(11):1824-30. doi: 10.1038/sj.leu.2403448. Leukemia. 2004. PMID: 15318246

2

Persistence of E2A/PBX1 transcripts in t(1;19) childhood acute lymphoblastic leukemia: correlation with chemotherapy intensity and clinical outcome.

Lanza C, Gottardi E, Gaidano G, Vivenza C, Parziale A, Perfetto F, Fornaci M, Barisone E, Madon E, Basso G, Saglio G. Lanza C, et al. Among authors: gottardi e. Leuk Res. 1996 May;20(5):441-3. doi: 10.1016/0145-2126(95)00115-8. Leuk Res. 1996. PMID: 8683984

3

Assessment of minimal residual disease (MRD) in CBFbeta/MYH11-positive acute myeloid leukemias by qualitative and quantitative RT-PCR amplification of fusion transcripts.

Guerrasio A, Pilatrino C, De Micheli D, Cilloni D, Serra A, Gottardi E, Parziale A, Marmont F, Diverio D, Divona M, Lo Coco F, Saglio G. Guerrasio A, et al. Among authors: gottardi e. Leukemia. 2002 Jun;16(6):1176-81. doi: 10.1038/sj.leu.2402478. Leukemia. 2002. PMID: 12040450

4

Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patients.

Cilloni D, Gottardi E, De Micheli D, Serra A, Volpe G, Messa F, Rege-Cambrin G, Guerrasio A, Divona M, Lo Coco F, Saglio G. Cilloni D, et al. Among authors: gottardi e. Leukemia. 2002 Oct;16(10):2115-21. doi: 10.1038/sj.leu.2402675. Leukemia. 2002. PMID: 12357365

5

Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program.

Beillard E, Pallisgaard N, van der Velden VH, Bi W, Dee R, van der Schoot E, Delabesse E, Macintyre E, Gottardi E, Saglio G, Watzinger F, Lion T, van Dongen JJ, Hokland P, Gabert J. Beillard E, et al. Among authors: gottardi e. Leukemia. 2003 Dec;17(12):2474-86. doi: 10.1038/sj.leu.2403136. Leukemia. 2003. PMID: 14562124

6

Quantitative assessment of minimal residual disease in acute myeloid leukemia carrying nucleophosmin (NPM1) gene mutations.

Gorello P, Cazzaniga G, Alberti F, Dell'Oro MG, Gottardi E, Specchia G, Roti G, Rosati R, Martelli MF, Diverio D, Lo Coco F, Biondi A, Saglio G, Mecucci C, Falini B. Gorello P, et al. Among authors: gottardi e. Leukemia. 2006 Jun;20(6):1103-8. doi: 10.1038/sj.leu.2404149. Leukemia. 2006. PMID: 16541144

7

The common TEL/AML1 rearrangement does not represent a frequent event in acute lymphoblastic leukaemia occuring in children with Down syndrome.

Lanza C, Volpe G, Basso G, Gottardi E, Perfetto F, Cilli V, Spinelli M, Ricotti E, Guerrasio A, Madon E, Saglio G. Lanza C, et al. Among authors: gottardi e. Leukemia. 1997 Jun;11(6):820-1. doi: 10.1038/sj.leu.2400651. Leukemia. 1997. PMID: 9177434

8

Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia.

van Dongen JJ, Macintyre EA, Gabert JA, Delabesse E, Rossi V, Saglio G, Gottardi E, Rambaldi A, Dotti G, Griesinger F, Parreira A, Gameiro P, Diáz MG, Malec M, Langerak AW, San Miguel JF, Biondi A. van Dongen JJ, et al. Among authors: gottardi e. Leukemia. 1999 Dec;13(12):1901-28. doi: 10.1038/sj.leu.2401592. Leukemia. 1999. PMID: 10602411 Review.

9

WT1 overexpression in acute myeloid leukemia and myelodysplastic syndromes.

Cilloni D, Gottardi E, Saglio G. Cilloni D, et al. Among authors: gottardi e. Methods Mol Med. 2006;125:199-211. doi: 10.1385/1-59745-017-0:199. Methods Mol Med. 2006. PMID: 16502587

10

Erythroid response and decrease of WT1 expression after proteasome inhibition by bortezomib in myelodysplastic syndromes.

Alimena G, Breccia M, Musto P, Cilloni D, D'Auria F, Latagliata R, Sanpaolo G, Gottardi E, Saglio G, Mandelli F. Alimena G, et al. Among authors: gottardi e. Leuk Res. 2011 Apr;35(4):504-7. doi: 10.1016/j.leukres.2010.08.021. Epub 2010 Oct 23. Leuk Res. 2011. PMID: 20971509 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

117 results

Search Page

Filters